{"slug":"biomarkers-by-cancers","title":"Biomarker terms by number of cancers","basis":"Glossary terms in the Biomarkers category ordered by how many cancers are linked to them from either side.","metric":"Cancers","context":"Products linked","how":"Takes glossary terms whose category is Biomarkers and counts distinct cancer records that either appear in the term's cancers field or list the term in their own terms field. The context column counts product records that list the term.","coverage":{"filled":120,"of":126,"what":"biomarker terms are linked to at least one cancer","share":0.952},"total":120,"top":50,"rows":[{"rank":1,"id":"msi","name":"Microsatellite instability (MSI-H) / mismatch repair deficiency (dMMR)","kind":"term","route":"/terms/msi/","value":28,"metric":"28","context":"3 products"},{"rank":2,"id":"ctdna","name":"Circulating tumour DNA (ctDNA)","kind":"term","route":"/terms/ctdna/","value":24,"metric":"24","context":"6 products"},{"rank":3,"id":"mrd","name":"Minimal / molecular residual disease (MRD)","kind":"term","route":"/terms/mrd/","value":23,"metric":"23","context":"4 products"},{"rank":4,"id":"hpv-p16","name":"HPV-positive (p16) head and neck cancer","kind":"term","route":"/terms/hpv-p16/","value":20,"metric":"20","context":"0 products"},{"rank":5,"id":"tmb","name":"Tumour mutational burden (TMB)","kind":"term","route":"/terms/tmb/","value":18,"metric":"18","context":"1 product"},{"rank":6,"id":"cdkn2a-homozygous-deletion","name":"CDKN2A/B homozygous deletion","kind":"term","route":"/terms/cdkn2a-homozygous-deletion/","value":17,"metric":"17","context":"0 products"},{"rank":7,"id":"tumour-markers","name":"Tumour markers (CEA, LDH, chromogranin, thyroglobulin)","kind":"term","route":"/terms/tumour-markers/","value":17,"metric":"17","context":"0 products"},{"rank":8,"id":"ebv-term","name":"Epstein-Barr virus (EBV) in cancer","kind":"term","route":"/terms/ebv-term/","value":15,"metric":"15","context":"0 products"},{"rank":9,"id":"lymphoma-b-versus-t-cell","name":"B-cell, T-cell and NK-cell lymphoma","kind":"term","route":"/terms/lymphoma-b-versus-t-cell/","value":13,"metric":"13","context":"0 products"},{"rank":10,"id":"cps","name":"Combined positive score (CPS)","kind":"term","route":"/terms/cps/","value":13,"metric":"13","context":"1 product"},{"rank":11,"id":"afp","name":"Alpha-fetoprotein (AFP)","kind":"term","route":"/terms/afp/","value":12,"metric":"12","context":"1 product"},{"rank":12,"id":"gbrca-mutation","name":"Germline BRCA mutation (gBRCA)","kind":"term","route":"/terms/gbrca-mutation/","value":12,"metric":"12","context":"1 product"},{"rank":13,"id":"braf-v600-mutation","name":"BRAF V600E mutation","kind":"term","route":"/terms/braf-v600-mutation/","value":11,"metric":"11","context":"0 products"},{"rank":14,"id":"ca19-9","name":"CA 19-9","kind":"term","route":"/terms/ca19-9/","value":11,"metric":"11","context":"0 products"},{"rank":15,"id":"hpv-status","name":"HPV status (HPV-positive / HPV-negative)","kind":"term","route":"/terms/hpv-status/","value":11,"metric":"11","context":"0 products"},{"rank":16,"id":"fish","name":"FISH / ISH (in situ hybridisation)","kind":"term","route":"/terms/fish/","value":9,"metric":"9","context":"2 products"},{"rank":17,"id":"hrd","name":"Homologous recombination deficiency (HRD)","kind":"term","route":"/terms/hrd/","value":9,"metric":"9","context":"2 products"},{"rank":18,"id":"tp53-mutated","name":"TP53-mutated (p53-abnormal)","kind":"term","route":"/terms/tp53-mutated/","value":9,"metric":"9","context":"0 products"},{"rank":19,"id":"depth-of-invasion","name":"Depth of invasion (DOI)","kind":"term","route":"/terms/depth-of-invasion/","value":8,"metric":"8","context":"0 products"},{"rank":20,"id":"myd88-l265p","name":"MYD88 L265P and CXCR4 mutations","kind":"term","route":"/terms/myd88-l265p/","value":8,"metric":"8","context":"0 products"},{"rank":21,"id":"b-all-cytogenetic-risk","name":"B-ALL risk groups (NCI criteria, ETV6::RUNX1, hyperdiploidy, hypodiploidy, iAMP21, IKZF1, CNS status)","kind":"term","route":"/terms/b-all-cytogenetic-risk/","value":7,"metric":"7","context":"0 products"},{"rank":22,"id":"brca-reversion-mutations","name":"BRCA reversion mutations","kind":"term","route":"/terms/brca-reversion-mutations/","value":7,"metric":"7","context":"0 products"},{"rank":23,"id":"cytogenetics","name":"Cytogenetics and karyotype","kind":"term","route":"/terms/cytogenetics/","value":7,"metric":"7","context":"0 products"},{"rank":24,"id":"extranodal-extension","name":"Extranodal extension (ENE)","kind":"term","route":"/terms/extranodal-extension/","value":7,"metric":"7","context":"0 products"},{"rank":25,"id":"kras-mutation-subtypes","name":"KRAS mutation subtypes (G12C, G12D, G12V)","kind":"term","route":"/terms/kras-mutation-subtypes/","value":7,"metric":"7","context":"2 products"},{"rank":26,"id":"m-protein-free-light-chains","name":"M-protein, immunofixation and serum free light chains","kind":"term","route":"/terms/m-protein-free-light-chains/","value":7,"metric":"7","context":"0 products"},{"rank":27,"id":"plasma-ebv-dna","name":"Plasma EBV DNA","kind":"term","route":"/terms/plasma-ebv-dna/","value":7,"metric":"7","context":"0 products"},{"rank":28,"id":"pten-loss","name":"PTEN loss","kind":"term","route":"/terms/pten-loss/","value":7,"metric":"7","context":"0 products"},{"rank":29,"id":"sf3b1-mutation","name":"SF3B1 mutation","kind":"term","route":"/terms/sf3b1-mutation/","value":7,"metric":"7","context":"0 products"},{"rank":30,"id":"bap1-loss","name":"BAP1 loss","kind":"term","route":"/terms/bap1-loss/","value":6,"metric":"6","context":"0 products"},{"rank":31,"id":"flow-cytometry","name":"Flow cytometry (immunophenotyping)","kind":"term","route":"/terms/flow-cytometry/","value":6,"metric":"6","context":"0 products"},{"rank":32,"id":"gene-amplification","name":"Gene amplification and copy-number change","kind":"term","route":"/terms/gene-amplification/","value":6,"metric":"6","context":"0 products"},{"rank":33,"id":"her2-positive","name":"HER2-positive (IHC 3+ or ISH-amplified)","kind":"term","route":"/terms/her2-positive/","value":6,"metric":"6","context":"1 product"},{"rank":34,"id":"mlh1-promoter-methylation","name":"MLH1 promoter methylation (sporadic versus Lynch mismatch repair loss)","kind":"term","route":"/terms/mlh1-promoter-methylation/","value":6,"metric":"6","context":"0 products"},{"rank":35,"id":"psa","name":"PSA (prostate-specific antigen)","kind":"term","route":"/terms/psa/","value":6,"metric":"6","context":"2 products"},{"rank":36,"id":"receptor-conversion-breast","name":"Receptor conversion: when the receptors change between the primary and a recurrence","kind":"term","route":"/terms/receptor-conversion-breast/","value":6,"metric":"6","context":"0 products"},{"rank":37,"id":"tps","name":"Tumour proportion score (TPS)","kind":"term","route":"/terms/tps/","value":6,"metric":"6","context":"0 products"},{"rank":38,"id":"umrd","name":"Undetectable MRD (uMRD / MRD-negative)","kind":"term","route":"/terms/umrd/","value":6,"metric":"6","context":"1 product"},{"rank":39,"id":"btki-bcl2i-resistance-mutations","name":"BTK C481S, PLCG2 and BCL2 G101V resistance mutations","kind":"term","route":"/terms/btki-bcl2i-resistance-mutations/","value":5,"metric":"5","context":"0 products"},{"rank":40,"id":"chromogranin-a","name":"Chromogranin A","kind":"term","route":"/terms/chromogranin-a/","value":5,"metric":"5","context":"0 products"},{"rank":41,"id":"del17p-tp53","name":"del(17p) / TP53 aberration in CLL","kind":"term","route":"/terms/del17p-tp53/","value":5,"metric":"5","context":"0 products"},{"rank":42,"id":"double-hit-lymphoma","name":"Double-hit / high-grade B-cell lymphoma","kind":"term","route":"/terms/double-hit-lymphoma/","value":5,"metric":"5","context":"0 products"},{"rank":43,"id":"extended-ras-testing","name":"Extended RAS testing","kind":"term","route":"/terms/extended-ras-testing/","value":5,"metric":"5","context":"0 products"},{"rank":44,"id":"her2-testing-uk-breast","name":"HER2 testing in the UK: reflex ISH, the ratio against the copy number, and where the UK differs from ASCO/CAP","kind":"term","route":"/terms/her2-testing-uk-breast/","value":5,"metric":"5","context":"0 products"},{"rank":45,"id":"her2-low","name":"HER2-low and HER2-ultralow","kind":"term","route":"/terms/her2-low/","value":5,"metric":"5","context":"2 products"},{"rank":46,"id":"er-pr-scoring-breast","name":"How ER and PR are scored on a breast report (Allred score, H score, and why PR is not a UK core item)","kind":"term","route":"/terms/er-pr-scoring-breast/","value":5,"metric":"5","context":"0 products"},{"rank":47,"id":"mss-pmmr","name":"Microsatellite-stable (MSS) / mismatch-repair proficient (pMMR)","kind":"term","route":"/terms/mss-pmmr/","value":5,"metric":"5","context":"1 product"},{"rank":48,"id":"gatekeeper-mutation","name":"On-target resistance mutations (gatekeeper, solvent-front, compound)","kind":"term","route":"/terms/gatekeeper-mutation/","value":5,"metric":"5","context":"0 products"},{"rank":49,"id":"pd-l1-testing","name":"PD-L1 expression testing (22C3, SP142, SP263)","kind":"term","route":"/terms/pd-l1-testing/","value":5,"metric":"5","context":"3 products"},{"rank":50,"id":"philadelphia-chromosome","name":"Philadelphia chromosome (Ph+, BCR::ABL1)","kind":"term","route":"/terms/philadelphia-chromosome/","value":5,"metric":"5","context":"0 products"}]}